Learn about the feasibility of rapid lung NGS testing in this 20-minute webinar presented by Dr. Fernando López-RÃos, a distinguished pathologist from "12 de Octubre" University Hospital in Madrid. Gain insights from an expert with extensive experience in cancer biomarker testing, particularly in lung cancer and mesothelioma. Dr. López-RÃos, a member of the IASLC Pathology Committee and former Director of Pathology & Laboratory of Therapeutic Targets at "HM Hospitales," shares his expertise developed through his medical career, including research at Memorial Sloan Kettering Cancer Center. Healthcare professionals can earn PACE credits through Labroots upon completion of the webinar, valid until March 29, 2025.
Feasibility of Rapid Lung NGS Testing in Cancer Diagnostics
Overview
Syllabus
Feasibility of rapid lung NGS testing
Taught by
Labroots
Related Courses
-
Clinical Utility of NGS in Liquid Biopsy for Lung Cancer
-
Development of a Novel Targeted NGS Panel for Analysis of DNA Methylation Biomarkers in Lung Cancer
-
Utilization of the Genexus Turnkey NGS Platform for Molecular Profiling of NSCLC Samples
-
Comprehensive Molecular Diagnostics and Advanced Gene Expression Analysis
-
Rapid Tissue-Based Molecular Testing in Oncology - Clinical Utility of Amplicon-Based Comprehensive Testing
-
Identifying Clinically Relevant Mutations in Somatic NGS Testing
